Back
HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 862592Generated: October 30, 2026

4-Tert-butoxycarbonylaminomethyl-2-(1-methoxycarbonyl-1-acetoxymethyl) aniline → (5S)-9-Chloro-5-[p-tert-butoxycarbonylaminomethyl-o-(1-methoxycarbonyl-1-acetoxymethyl) phenylcarbamoylmethyl]-6,7-dihydro-1H, 5H-pyrido[1,2,3-de]quinoxaline-2,3-dione

https://huagongshe.com/reaction/862592

Reaction equation

Participants

RoleNameHCIDCharge
Reactant4-Tert-butoxycarbonylaminomethyl-2-(1-methoxycarbonyl-1-acetoxymethyl) anilineHCID 19698361—
Reactant(S)-9-chloro-5-carboxymethyl-6,7-dihydro-1H, 5H-pyrido[1,2,3-de]quinoxaline-2,3-dioneHCID 131720478—
Product(5S)-9-Chloro-5-[p-tert-butoxycarbonylaminomethyl-o-(1-methoxycarbonyl-1-acetoxymethyl) phenylcarbamoylmethyl]-6,7-dihydro-1H, 5H-pyrido[1,2,3-de]quinoxaline-2,3-dioneHCID 13172049043.7%

Reaction Steps

A procedure similar to that described in Example 9-7) was performed with 4-tert-butoxycarbonylaminomethyl-2-(1-methoxycarbonyl-1-acetoxymethyl) aniline (500 mg, 1 mmol) and (S)-9-chloro-5-carboxymethyl-6,7-dihydro-1H, 5H-pyrido[1,2,3-de]quinoxaline-2,3-dione (413 mg, 1.4 mmol) to give 275 mg of the title compound (43.7%).

Provenance & Evidence

DOI10.6084/m9.figshare.5104873.v1
Patent numberUS05719152
Source datasetuspto-grants-1998_02
ORD IDord-11e9dd9e8807452cb4bd19bed41c0633
Source noteuspto-grants-1998_02